Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A25700 | 21525770 | Digestion | Carotid intima-media thickness is increased not only in non-alcoholic fatty liver disease patients but also in alcoholic fatty liver patients. | 2011 | Details |
| A25701 | 21521847 | JAMA | Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial. | 2011 | Details |
| A25702 | 21521338 | Clin Endocrinol (Oxf) | Serum fetuin-A concentrations are elevated in subjects with impaired glucose tolerance and newly diagnosed type 2 diabetes. | 2011 | Details |
| A25703 | 21521307 | Clin Endocrinol (Oxf) | Correlation of insulin sensitivity with bone mineral status in obese adolescents with nonalcoholic fatty liver disease. | 2011 | Details |
| A25705 | 21521285 | Clin Endocrinol (Oxf) | Association between thyroid function and nonalcoholic fatty liver disease in euthyroid elderly Chinese. | 2011 | Details |
| A25706 | 21520200 | Hepatology | Endpoints and clinical trial design for nonalcoholic steatohepatitis. | 2011 | Details |
| A25709 | 21519163 | Korean J Gastroenterol | [Association among histopathology, clinical manifestation, and ultrasonographic grades in pediatric non-alcoholic fatty liver disease]. | 2011 | Details |
| A25711 | 21518734 | Arch Dis Child | Lifestyle intervention for non-alcoholic fatty liver disease: prospective cohort study of its efficacy and factors related to improvement. | 2011 | Details |
| A25712 | 21518594 | Chin Med J (Engl) | Association between non-alcoholic fatty liver disease and coronary artery disease severity. | 2011 | Details |
| A25713 | 21517924 | Aliment Pharmacol Ther | Reliability of liver stiffness measurement in non-alcoholic fatty liver disease: the effects of body mass index. | 2011 | Details |
| A25714 | 21516322 | Dig Dis Sci | Plasma free myristic acid proportion is a predictor of nonalcoholic steatohepatitis. | 2011 | Details |
| A25715 | 21514287 | Clin Chim Acta | The role of oxidative stress in non-alcoholic steatohepatitis. | 2011 | Details |
| A25716 | 21513939 | Atherosclerosis | Circulating vaspin levels and epicardial adipose tissue thickness are associated with impaired coronary flow reserve in patients with nonalcoholic fatty liver disease. | 2011 | Details |
| A25717 | 21512848 | J Gastrointest Surg | Surgical outcomes for hepatocellular carcinoma in nonalcoholic fatty liver disease. | 2011 | Details |
| A25718 | 21510837 | Curr Top Med Chem | A new perspective of cannabinoid 1 receptor antagonists: approaches toward peripheral CB1R blockers without crossing the blood-brain barrier. | 2011 | Details |
| A25719 | 21509233 | Sultan Qaboos Univ Med J | Non-Alcoholic Fatty Liver Disease (NAFLD) - Is it an Emerging Risk Factor for Coronary Artery Disease?: Preliminary study in a local Indian population. | 2010 | Details |
| A25720 | 21508207 | J Nutr | Rutin attenuates metabolic changes, nonalcoholic steatohepatitis, and cardiovascular remodeling in high-carbohydrate, high-fat diet-fed rats. | 2011 | Details |
| A25721 | 21507897 | FASEB J | Role for PPARγ in obesity-induced hepatic steatosis as determined by hepatocyte- and macrophage-specific conditional knockouts. | 2011 | Details |
| A25722 | 21504583 | Lipids Health Dis | High fat diet-induced non alcoholic fatty liver disease in rats is associated with hyperhomocysteinemia caused by down regulation of the transsulphuration pathway. | 2011 | Details |
| A25723 | 21504366 | Antioxid Redox Signal | Nrf2 inhibits LXRα-dependent hepatic lipogenesis by competing with FXR for acetylase binding. | 2011 | Details |
| A25724 | 21503909 | J Med Virol | Lymphoproliferative disorders in individuals with chronic hepatitis B and C in the Turkish population. | 2011 | Details |
| A25725 | 21502677 | Ann Hepatol | Familial hypobetalipoproteinemia in a hospital survey: genetics, metabolism and non-alcoholic fatty liver disease. | 2011 | Details |
| A25726 | 21502676 | Ann Hepatol | Lipid-bound sialic acid (LSA) in liver diseases of different etiologies. | 2011 | Details |
| A25727 | 21502673 | Ann Hepatol | Risk factors and predictors of non-alcoholic fatty liver disease in Taiwan. | 2011 | Details |
| A25728 | 21502672 | Ann Hepatol | Non-alcoholic fatty liver disease and the metabolic syndrome in an urban hospital serving an African community. | 2011 | Details |
| A25729 | 21499110 | Eur J Gastroenterol Hepatol | Validation of noninvasive biomarkers (FibroTest, SteatoTest, and NashTest) for prediction of liver injury in patients with morbid obesity. | 2011 | Details |
| A25730 | 21499089 | Curr Opin Cardiol | Liver function tests and statins. | 2011 | Details |
| A25731 | 21498305 | Acta Radiol | Unenhanced fat fraction ratios obtained by MR and enhanced T2* values with liver-specific MR contrast agents for diagnosis of non-alcoholic steatohepatitis in rats. | 2011 | Details |
| A25732 | 21497744 | Best Pract Res Clin Gastroenterol | Genetics and epigenetics in the fibrogenic evolution of chronic liver diseases. | 2011 | Details |
| A25733 | 21497743 | Best Pract Res Clin Gastroenterol | Liver fibrosis in paediatric liver diseases. | 2011 | Details |
| A25734 | 21497741 | Best Pract Res Clin Gastroenterol | Fibrosis in alcoholic and nonalcoholic steatohepatitis. | 2011 | Details |
| A25735 | 21495873 | Toxicol Mech Methods | Epigenetic priming of the metabolic syndrome. | 2011 | Details |
| A25736 | 21494075 | Korean J Hepatol | Association of serum alanine aminotransferase and γ-glutamyltransferase levels within the reference range with metabolic syndrome and nonalcoholic fatty liver disease. | 2011 | Details |
| A25737 | 21494074 | Korean J Hepatol | Development and validation of a simple index system to predict nonalcoholic fatty liver disease. | 2011 | Details |
| A25739 | 21492876 | J Surg Res | The effect of hepatic ischemia reperfusion injury in a murine model of nonalcoholic steatohepatitis. | 2011 | Details |
| A25740 | 21489294 | Lipids Health Dis | Protective effect of whey proteins against nonalcoholic fatty liver in rats. | 2011 | Details |
| A25741 | 21488946 | J Gastroenterol Hepatol | Inflammatory stress exacerbates hepatic cholesterol accumulation via increasing cholesterol uptake and de novo synthesis. | 2011 | Details |
| A25743 | 21488074 | Hepatology | Lack of de novo phosphatidylinositol synthesis leads to endoplasmic reticulum stress and hepatic steatosis in cdipt-deficient zebrafish. | 2011 | Details |
| A25745 | 21488066 | Hepatology | Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells. | 2011 | Details |
| A25746 | 21487569 | Int J Med Sci | Prevalence and etiology of abnormal liver tests in an adult population in Jilin, China. | 2011 | Details |
| A25747 | 21486894 | J Clin Pathol | Participation of bile ductular cells in the pathological progression of non-alcoholic fatty liver disease. | 2011 | Details |
| A25748 | 21484137 | Hepatol Int | Non-cirrhotic portal fibrosis related end stage liver disease in adults: evaluation from a study on living donor liver transplant recipients. | 2011 | Details |
| A25749 | 21484130 | Hepatol Int | Renal function and severity of bright liver. Relationship with insulin resistance, intrarenal resistive index, and glomerular filtration rate. | 2011 | Details |
| A25750 | 21483633 | World J Gastroenterol | Intrahepatic natural killer T cell populations are increased in human hepatic steatosis. | 2011 | Details |
| A25751 | 21480410 | Phytother Res | A combination of grape extract, green tea extract and L-carnitine improves high-fat diet-induced obesity, hyperlipidemia and non-alcoholic fatty liver disease in mice. | 2011 | Details |
| A25753 | 21479224 | PLoS One | Tuberous sclerosis complex-1 deficiency attenuates diet-induced hepatic lipid accumulation. | 2011 | Details |
| A25754 | 21478462 | Diabetes Care | Prevalence of and risk factors for hepatic steatosis and nonalcoholic Fatty liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. | 2011 | Details |
| A25755 | 21477300 | Lipids Health Dis | Systematic review on the treatment of pentoxifylline in patients with non-alcoholic fatty liver disease. | 2011 | Details |
| A25756 | 21476922 | Expert Rev Gastroenterol Hepatol | Insulin resistance in nonalcoholic steatohepatitis: necessary but not sufficient - death of a dogma from analysis of therapeutic studies? | 2011 | Details |
| A25757 | 21476921 | Expert Rev Gastroenterol Hepatol | Organelle dysfunction in hepatitis C virus-associated steatosis: anything to learn from nonalcoholic steatohepatitis? | 2011 | Details |
| A25758 | 21476920 | Expert Rev Gastroenterol Hepatol | Genetic determinants of susceptibility and severity in nonalcoholic fatty liver disease. | 2011 | Details |
| A25759 | 21476919 | Expert Rev Gastroenterol Hepatol | Microsomal triglyceride transfer protein and nonalcoholic fatty liver disease. | 2011 | Details |
| A25760 | 21476918 | Expert Rev Gastroenterol Hepatol | Mitochondrial dysfunction in nonalcoholic steatohepatitis. | 2011 | Details |
| A25761 | 21476917 | Expert Rev Gastroenterol Hepatol | Hepatocellular ballooning in nonalcoholic steatohepatitis: the pathologist's perspective. | 2011 | Details |
| A25762 | 21476916 | Expert Rev Gastroenterol Hepatol | Cell death and nonalcoholic steatohepatitis: where is ballooning relevant? | 2011 | Details |
| A25763 | 21476915 | Expert Rev Gastroenterol Hepatol | Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications. | 2011 | Details |
| A25764 | 21476914 | Expert Rev Gastroenterol Hepatol | Inflammation in nonalcoholic steatohepatitis. | 2011 | Details |
| A25765 | 21476913 | Expert Rev Gastroenterol Hepatol | Fibrogenesis in nonalcoholic steatohepatitis. | 2011 | Details |
| A25766 | 21476912 | Expert Rev Gastroenterol Hepatol | The cytoskeleton in nonalcoholic steatohepatitis: 100 years old but still youthful. | 2011 | Details |
| A25767 | 21476911 | Expert Rev Gastroenterol Hepatol | Autophagy in nonalcoholic steatohepatitis. | 2011 | Details |
| A25771 | 21476786 | Ann Med | Statin-based treatment for cardiovascular risk and non-alcoholic fatty liver disease. Killing two birds with one stone? | 2011 | Details |
| A25772 | 21475632 | Int J Gen Med | The effects of diet-induced obesity on hepatocyte insulin signaling pathways and induction of non-alcoholic liver damage. | 2011 | Details |
| A25774 | 21474829 | Arterioscler Thromb Vasc Biol | Peroxisome proliferator-activated receptor-alpha gene level differently affects lipid metabolism and inflammation in apolipoprotein E2 knock-in mice. | 2011 | Details |
| A25776 | 21472332 | Mol Med Rep | Mammalian target of the rapamycin pathway is involved in non-alcoholic fatty liver disease. | 2010 | Details |
| A25777 | 21470125 | Curr Pharm Biotechnol | Methodologies for investigating natural medicines for the treatment of nonalcoholic fatty liver disease (NAFLD). | 2012 | Details |
| A25779 | 21464822 | Lab Invest | Fatty liver is associated with impaired activity of PPARγ-coactivator 1α (PGC1α) and mitochondrial biogenesis in mice. | 2011 | Details |
| A25780 | 21463618 | Eur J Pharmacol | A novel agonist of PPAR-γ based on barbituric acid alleviates the development of non-alcoholic fatty liver disease by regulating adipocytokine expression and preventing insulin resistance. | 2011 | Details |
| A25781 | 21463337 | Alcohol Clin Exp Res | A new model of interactive effects of alcohol and high-fat diet on hepatic fibrosis. | 2011 | Details |
| A25782 | 21460032 | Radiology | Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography. | 2011 | Details |
| A25783 | 21459536 | Eur J Radiol | Accurate fat fraction quantification by multiecho gradient-recalled-echo magnetic resonance at 1.5T in rats with nonalcoholic fatty liver disease. | 2011 | Details |
| A25784 | 21459211 | Lancet | Increasing burden of liver disease in patients with HIV infection. | 2011 | Details |
| A25785 | 21459158 | Clin Gastroenterol Hepatol | Factors that affect risk for hepatocellular carcinoma and effects of surveillance. | 2011 | Details |
| A25786 | 21457446 | Liver Int | Serum ferritin is a discriminant marker for both fibrosis and inflammation in histologically proven non-alcoholic fatty liver disease patients. | 2011 | Details |
| A25787 | 21457442 | Liver Int | Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: prevalences and correlated factors. | 2011 | Details |
| A25788 | 21455726 | Diabetologia | Apoptosis and insulin resistance in liver and peripheral tissues of morbidly obese patients is associated with different stages of non-alcoholic fatty liver disease. | 2011 | Details |
| A25790 | 21453696 | Eur J Pharmacol | Nitro-aspirin is a potential therapy for non alcoholic fatty liver disease. | 2011 | Details |
| A25791 | 21452138 | Ther Umsch | [Non-alcoholic steatohepatitis - from NAFLD to MAFLD]. | 2011 | Details |
| A25792 | 21451926 | Singapore Med J | Comparison of haematological parameters in patients with non-alcoholic fatty liver disease and alcoholic liver disease. | 2011 | Details |
| A25793 | 21451413 | Curr Opin Gastroenterol | Genetics in liver disease: new concepts. | 2011 | Details |
| A25794 | 21449949 | Diabetes Obes Metab | Current therapeutic strategies in non-alcoholic fatty liver disease. | 2011 | Details |
| A25796 | 24834161 | Gastroenterol Hepatol Bed Bench | The impact of breakfast in metabolic and digestive health. | 2011 | Details |
| A25797 | 22813407 | Diabetes Metab Syndr | Association of nonalcoholic fatty liver disease with metabolic syndrome in Indian population. | 2012 | Details |
| A25798 | 21449029 | Biotechnol Bioeng | Use of three-dimensional spheroids of hepatocyte-derived reporter cells to study the effects of intracellular fat accumulation and subsequent cytokine exposure. | 2011 | Details |
| A25799 | 21448953 | J Magn Reson Imaging | Effect of disease progression on liver apparent diffusion coefficient values in a murine model of NASH at 11.7 Tesla MRI. | 2011 | Details |
| A25800 | 21446920 | Clin Sci (Lond) | Methionine and protein metabolism in non-alcoholic steatohepatitis: evidence for lower rate of transmethylation of methionine. | 2011 | Details |
| A25801 | 21445622 | Eur J Nutr | Dietary d-limonene alleviates insulin resistance and oxidative stress-induced liver injury in high-fat diet and L-NAME-treated rats. | 2011 | Details |
| A25802 | 21442288 | Virchows Arch | Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease. | 2011 | Details |
| A25803 | 21440836 | Biomed Environ Sci | Impacts of types and degree of obesity on non-alcoholic fatty liver disease and related dyslipidemia in Chinese school-age children? | 2011 | Details |
| A25804 | 21440778 | Transplant Proc | De novo fatty liver due to vascular complications after liver transplantation. | 2011 | Details |
| A25805 | 21440669 | Clin Gastroenterol Hepatol | Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. | 2011 | Details |
| A25806 | 21440524 | Clin Res Hepatol Gastroenterol | Vitamin D and the vitamin D receptor in liver pathophysiology. | 2011 | Details |
| A25808 | 21439567 | Atherosclerosis | Diet, commensals and the intestine as sources of pathogen-associated molecular patterns in atherosclerosis, type 2 diabetes and non-alcoholic fatty liver disease. | 2011 | Details |
| A25809 | 21438811 | Expert Rev Cardiovasc Ther | Hepatic steatosis and Type 2 diabetes: current and future treatment considerations. | 2011 | Details |
| A25810 | 21438662 | DNA Cell Biol | Association of polymorphisms in glutamate-cysteine ligase catalytic subunit and microsomal triglyceride transfer protein genes with nonalcoholic fatty liver disease. | 2011 | Details |
| A25811 | 21436212 | J Renin Angiotensin Aldosterone Syst | Effect of spironolactone and vitamin E on serum metabolic parameters and insulin resistance in patients with nonalcoholic fatty liver disease. | 2011 | Details |
| A25812 | 21436037 | Proc Natl Acad Sci U S A | Hepatic insulin resistance in mice with hepatic overexpression of diacylglycerol acyltransferase 2. | 2011 | Details |
| A25813 | 21434863 | Curr HIV Res | Non-alcoholic fatty liver disease in HIV infection associated with altered hepatic fatty acid composition. | 2011 | Details |
| A25814 | 21431854 | Curr Diab Rep | Why does NAFLD predict type 2 diabetes? | 2011 | Details |
| A25815 | 21430606 | Pol Arch Med Wewn | Rosiglitazone treatment in nondiabetic subjects with nonalcoholic fatty liver disease. | 2011 | Details |
| A25816 | 21429837 | Clin Res Hepatol Gastroenterol | Lack of association of GSTT1 and GSTP1 genes methylation and their expression profiles with risk of NAFLD in a sample of Iranian patients. | 2011 | Details |